Clinical trials/studies
For patients
In our study center the focus is on phase II and III studies.
- current clinical studies on the following indications:
| Prostate Cancer | |
|---|---|
A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer | ARASTEP |
| Urothelial carcinoma (bladder, upper urinary tract) | |
A Study of Pembrolizumab (MK3475) Plus V940 in Participants With Bladder Cancer Post-Radical Resection | V940-005 |
| Renal cell carcinoma | |
Virtual Interactive 3D Modelling to improve Outcomes in Robotic-Assisted Partial Nephrectomy – A Multicentre, Randomised, Controlled Trial | 3DPN |
For more information, see: ClinicalTrials.gov
If you have any questions in this context or would like to take part in one of the studies in our clinic, please contact us.
Contact:
